RUBICON NSE filing

Rubicon Research Monitoring Agency Report for Q4 FY26: No Deviation in IPO Fund Utilization

The RealCase readLow impact Neutral

Rubicon Research's Monitoring Agency Report for Q4 FY26 confirms no deviation in IPO fund utilization. Total IPO size was ₹13,775 million (₹1,377.5 crore). As of March 31, 2026, ₹3,351.45 million (₹335.15 crore) of IPO proceeds have been utilized, with ₹1,648.55 million (₹164.86 crore) unutilized. Unutilized funds are invested in FDs earning up to 7.05%.

Why it matters

This is a routine monitoring report confirming compliance with IPO fund utilization as per regulations. It does not involve new financial performance, strategic changes, or events that would significantly impact the company's operations or stock price.

The market read

The report is a routine compliance filing confirming no deviation in IPO fund utilization, which is a standard procedural update. While positive in that there are no issues, it does not present new financial performance data or strategic shifts.

Rubicon Research Limited has submitted its Monitoring Agency Report for the quarter ended March 31, 2026. The report, issued by India Ratings & Research Private Limited, confirms no deviation from the objects for which the Initial Public Offer (IPO) proceeds were utilized. The IPO, which occurred from October 9 to October 13, 2025, had a total issue size of ₹13,775 million (approximately ₹1,377.5 crore), comprising an offer for sale of ₹8,775 million (₹877.5 crore) and a fresh issue of ₹5,000 million (₹500 crore).

During the quarter, ₹2,646.41 million (₹264.64 crore) was utilized for the prepayment or scheduled repayment of outstanding borrowings, out of a total allocated amount of ₹3,100 million (₹310 crore). For funding inorganic growth and general corporate purposes, ₹590.05 million (₹59.01 crore) was utilized, with ₹1,022.69 million (₹102.27 crore) remaining unutilized from the allocated ₹1,612.74 million (₹161.27 crore). Offer-related expenses accounted for ₹114.99 million (₹11.5 crore) of the ₹287.26 million (₹28.73 crore) allocated. In total, ₹3,351.45 million (₹335.15 crore) was utilized during the quarter, with ₹1,648.55 million (₹164.86 crore) remaining unutilized.

The unutilized IPO proceeds are deployed in fixed deposits with HDFC and Axis banks, totaling ₹1,648.55 million (₹164.86 crore) as of March 31, 2026. These FDs have maturity dates ranging from July 2026 to March 2027 and are earning interest rates between 6.25% and 7.05%. The company has also transferred funds to various current and cash credit accounts, leading to commingling of funds, but has provided necessary documentation for utilization. The report will be presented to the Audit Committee and the Board along with the year-end financial results.

Filing to action

What to do with a filing like this

Rubicon Research Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Rubicon Research Limited. Read the original for the full detail.

View original filing